At Fresenius Kabi, we're doing More in America.
Our purpose is caring for life - putting lifesaving medicines and technologies in the hands of people who care for patients and finding solutions to the challenges they face. We work shoulder-to-shoulder with heath care professionals to help improve medication safety, design products that are easy to use, and help make medicines more accessible and affordable across the continuum of care in America.
Today, Fresenius Kabi offers one of the broadest U.S. portfolios of injectable pharmaceutical products for anesthesia and analgesia, anti-infective therapy, critical care, oncology and parenteral nutrition.
More Supply in America
Over the past five years, Fresenius Kabi has invested nearly $1 billion to expand and modernize advanced U.S. pharmaceutical production and distribution facilities. More than 70% of our pharmaceuticals for the U.S. are proudly formulated, filled and packaged in the U.S.1
More Support in America
Putting confidence within reach. Our people, products and processes are all focused on supporting our customers in America and helping to bring more confidence to clinicians and their patients.
Bringing more products to market that can help improve safety and efficiency for physicians, pharmacists, nurses and patients.
_rdax_694x259.png){kind=logo}
What this all adds up to is more access for patients to the medications they need and less vulnerability when there are increased supply demands and other disruptions. We invite you to explore more about how Fresenius Kabi is doing More in America to serve you better at moreinamerica.com.
- 2022 data on file.
- Penoyer D, Guiliano K, Middleton A. BMJ Innov Epub ahead of print: 18April2022 doi:10.1136/bmjinnov- 2021-000851. Compares Ivenix to a single competitor